ATE529440T1 - Biologisch aktives peptid und wirkstoff, der dieses enthält - Google Patents

Biologisch aktives peptid und wirkstoff, der dieses enthält

Info

Publication number
ATE529440T1
ATE529440T1 AT08006914T AT08006914T ATE529440T1 AT E529440 T1 ATE529440 T1 AT E529440T1 AT 08006914 T AT08006914 T AT 08006914T AT 08006914 T AT08006914 T AT 08006914T AT E529440 T1 ATE529440 T1 AT E529440T1
Authority
AT
Austria
Prior art keywords
peptide
active ingredient
containing same
ingredient containing
seq
Prior art date
Application number
AT08006914T
Other languages
English (en)
Inventor
Takashi Takata
Shoji Kitagawa
Yuji Kaneda
Original Assignee
Seikagaku Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikagaku Kogyo Co Ltd filed Critical Seikagaku Kogyo Co Ltd
Application granted granted Critical
Publication of ATE529440T1 publication Critical patent/ATE529440T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
AT08006914T 2003-02-21 2004-02-20 Biologisch aktives peptid und wirkstoff, der dieses enthält ATE529440T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003045166 2003-02-21
JP2003142845A JP2004307454A (ja) 2003-02-21 2003-05-21 生理活性ペプチド及びこれを含有する薬剤

Publications (1)

Publication Number Publication Date
ATE529440T1 true ATE529440T1 (de) 2011-11-15

Family

ID=32911432

Family Applications (2)

Application Number Title Priority Date Filing Date
AT04713248T ATE466025T1 (de) 2003-02-21 2004-02-20 Physiologisch aktive peptide und medikamente, die diese enthalten
AT08006914T ATE529440T1 (de) 2003-02-21 2004-02-20 Biologisch aktives peptid und wirkstoff, der dieses enthält

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT04713248T ATE466025T1 (de) 2003-02-21 2004-02-20 Physiologisch aktive peptide und medikamente, die diese enthalten

Country Status (7)

Country Link
US (2) US7365153B2 (de)
EP (2) EP2000478B1 (de)
JP (3) JP2004307454A (de)
AT (2) ATE466025T1 (de)
DE (1) DE602004026840D1 (de)
ES (2) ES2347245T3 (de)
WO (1) WO2004074319A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004307454A (ja) * 2003-02-21 2004-11-04 Seikagaku Kogyo Co Ltd 生理活性ペプチド及びこれを含有する薬剤
US8707326B2 (en) * 2012-07-17 2014-04-22 Concurix Corporation Pattern matching process scheduler in message passing environment
US9575813B2 (en) 2012-07-17 2017-02-21 Microsoft Technology Licensing, Llc Pattern matching process scheduler with upstream optimization
CN119241640B (zh) * 2024-12-06 2025-04-25 杭州康源食品科技有限公司 一种促进骨骼生长的三肽

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL324518A1 (en) 1995-07-13 1998-06-08 Biora Ab Polypeptide showing affinity to enamel matrix
US6300062B1 (en) * 1995-07-13 2001-10-09 Biora Ab Enamel matrix related polypeptide
US20010039335A1 (en) * 1997-04-10 2001-11-08 Kenneth Jacobs Secreted proteins and polynucleotides encoding them
CA2316973A1 (en) 1998-01-07 1999-07-15 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
JP4726296B2 (ja) * 1998-02-27 2011-07-20 インスティチュート ストローマン アーゲー 創傷治癒のためのマトリックスタンパク質組成物
ES2183510T3 (es) 1998-02-27 2003-03-16 Biora Bioex Ab Composiciones de proteinas de matriz para la cicatrizacion de heridas.
ATE258442T1 (de) * 1999-03-10 2004-02-15 Biora Bioex Ab Matrixprotein zusammensetzungen für pfropfung in nicht mineralisierten geweben
CN1302883A (zh) * 1999-10-29 2001-07-11 上海博道基因技术有限公司 一种新的多肽——人成釉质蛋白23和编码这种多肽的多核苷酸
JP2004307454A (ja) * 2003-02-21 2004-11-04 Seikagaku Kogyo Co Ltd 生理活性ペプチド及びこれを含有する薬剤

Also Published As

Publication number Publication date
US20090137482A1 (en) 2009-05-28
US7365153B2 (en) 2008-04-29
JPWO2004074319A1 (ja) 2006-06-01
EP1602665A1 (de) 2005-12-07
ATE466025T1 (de) 2010-05-15
EP1602665A4 (de) 2007-07-18
JP4630816B2 (ja) 2011-02-09
JP5047323B2 (ja) 2012-10-10
ES2347245T3 (es) 2010-10-27
DE602004026840D1 (de) 2010-06-10
EP2000478A1 (de) 2008-12-10
ES2378711T3 (es) 2012-04-17
JP2010189399A (ja) 2010-09-02
EP2000478B1 (de) 2011-10-19
US20060172947A1 (en) 2006-08-03
JP2004307454A (ja) 2004-11-04
US7678884B2 (en) 2010-03-16
EP1602665B1 (de) 2010-04-28
WO2004074319A1 (ja) 2004-09-02

Similar Documents

Publication Publication Date Title
ATE494904T1 (de) Verbindungen und verfahren zur erhöhung der neurogenese
BR0111718A (pt) Peptìdeos quimicamente modificados, composições e métodos de produção e uso
IL150223A (en) Lipopeptides and pharmaceuticals containing them
SV1996000033A (es) Isotiazolonas
ATE531729T1 (de) Kdr-peptide und diese enthaltende impfstoffe
MXPA02006028A (es) Lipopeptidos novedosos como agentes antibacterianos.
LU92976I2 (en) Asfotase alfa
ATE496060T1 (de) Proteinartige verbindungen und anwendungen davon
DE60133802D1 (de) Verwendung von säurestabilen proteasen in tierfutter
AR036196A1 (es) Agentes de contraste multimericos dirigidos a base de peptidos
BRPI0413002A (pt) genes de ciclo de célula de planta e métodos de uso
AR023130A1 (es) Composiciones para promover el crecimiento
ATE481987T1 (de) Verfahren zur radiofluoridierung von biologisch aktiven vektoren
MXPA02006030A (es) Lipopeptidos como agentes antibacterianos.
MXPA02000465A (es) Derivados ciclopeptidicos como inhibidores de la integrina alfav beta6.
ATE430165T1 (de) Peptide mit integrinbindungsmotiv und behandlungsmethoden für muskelkrankheiten
DE60234822D1 (de) Lipoxygenase-varianten und ihre verwendung
AR021695A1 (es) 4,5-pirazinoxindoles, composicion farmaceutica y uso
PL1555260T3 (pl) Związki fenylotetrazolu
ATE481420T1 (de) Il-21-derivate
EP1602665A4 (de) Physiologisch aktive peptide und medikamente, die diese enthalten
DE69735039D1 (de) Acetylhydrolase des Plättchen aktivierenden Faktors, und entsprechendes Gen
ATE409499T1 (de) Verwendung von antiseptischen wirkstoffen in pmma-knochenzementen
DE69333351T2 (de) Rekombinante lipase aus hundemagen und pharmazeutische zusammensetzungen
DE60135489D1 (de) Lactam dipeptid und dessen verwendung zur inhibierung der beta-amyloid peptid frisetzung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties